Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial (vol 2, e1918254, 2019)

被引：5
|
作者：
Rosenberg, R.
Murphy, P.
Zammit, G.
机构：
来源：
JAMA NETWORK OPEN | 2020年 / 3卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2020.6497
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 14 条
  • [1] Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial (vol 2, e1918254, 2019)
    Rosenberg, Russell
    Murphy, Patricia
    Zammit, Gary
    [J]. JAMA NETWORK OPEN, 2021, 4 (08)
  • [2] Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder A Phase 3 Randomized Clinical Trial
    Rosenberg, Russell
    Murphy, Patricia
    Zammit, Gary
    Mayleben, David
    Kumar, Dinesh
    Dhadda, Shobha
    Filippov, Gleb
    LoPresti, Antonia
    Moline, Margaret
    [J]. JAMA NETWORK OPEN, 2019, 2 (12) : E1918254
  • [3] Comparison of the effect of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults with insomnia disorder
    Moline, Margaret
    Zammit, Gary
    Cheng, Jocelyn Y.
    Perdomo, Carlos
    Kumar, Dinesh
    Mayleben, David
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2021, 17 (06): : 1167 - 1174
  • [4] EFFECT OF LEMBOREXANT COMPARED WITH PLACEBO AND ZOLPIDEM EXTENDED RELEASE ON SLEEP ARCHITECTURE IN OLDER ADULTS WITH INSOMNIA DISORDER
    Moline, M.
    Pinner, K.
    Cheng, J.
    Perdomo, C.
    Kumar, D.
    Zammit, G.
    Mayleben, D.
    [J]. SLEEP MEDICINE, 2019, 64 : S437 - S437
  • [5] Comparison of lemborexant with zolpidem extended release and placebo: topline results from a phase 3 study in subjects 55 years and older with insomnia
    Rosenberg, R.
    Murphy, P.
    Chou, C.
    Dhadda, S.
    Zammit, G.
    Moline, M.
    [J]. JOURNAL OF SLEEP RESEARCH, 2018, 27
  • [6] Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings
    Inoue, Yuichi
    Nishida, Maika
    Kubota, Naoki
    Koebis, Michinori
    Taninaga, Takehiro
    Muramoto, Kenzo
    Ishikawa, Kohei
    Moline, Margaret
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2023, 19 (03): : 519 - 528
  • [7] Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2
    Karppa, Mikko
    Yardley, Jane
    Pinner, Kate
    Filippov, Gleb
    Zammit, Gary
    Moline, Margaret
    Perdomo, Carlos
    Inoue, Yuichi
    Ishikawa, Kohei
    Kubota, Naoki
    [J]. SLEEP, 2020, 43 (09) : 1 - 11
  • [8] Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial
    Yardley, Jane
    Karppa, Mikko
    Inoue, Yuichi
    Pinner, Kate
    Perdomo, Carlos
    Ishikawa, Kohei
    Filippov, Gleb
    Kubota, Naoki
    Moline, Margaret
    [J]. SLEEP MEDICINE, 2021, 80 : 333 - 342
  • [9] Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial (vol 4, e2033457, 2021)
    Heymsfield, S. B.
    Coleman, L. A.
    Miller, R.
    [J]. JAMA NETWORK OPEN, 2021, 4 (03)
  • [10] Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial (vol 4, e2033457, 2021)
    Heymsfield, S. B.
    Coleman, L. A.
    Miller, R.
    [J]. JAMA NETWORK OPEN, 2021, 4 (02)
12